The effect of black tea on risk factors of cardiovascular disease in a normal population

Preventive Medicine

Volumn 54, Issue SUPPL., 2012, Pages

  Bahorun, Theeshan ^a   Luximon Ramma, Amitabye ^a   Neergheen Bhujun, Vidushi S ^a   Gunness, Teeluck Kumar ^b   Googoolye, Kreshna ^a   Auger, Cyril ^c   Crozier, Alan ^d   Aruoma, Okezie I ^d  

^a UNIVERSITY OF MAURITIUS   (Mauritius)

^b Cardiac Centre   (Mauritius)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d American University of Health Sciences   (United States)

Author keywords

Black tea; Cardiovascular disease; Cholesterol; Fasting blood glucose; Human tea supplementation study; LDL HDL ratio; Plasma antioxidant capacity; Plasma lipids; Tea polyphenols

Indexed keywords

BLACK TEA EXTRACT; FLAVAN 3 OL; FLAVAN DERIVATIVE; FLAVONOL; GALLIC ACID DERIVATIVE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THEAFLAVIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MAURITIAN BLACK TEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TEA; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; TEA; TRIGLYCERIDES;

EID: 84860854440     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2011.12.009     Document Type: Article

References (22)

1. Benzie I.F.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of 'antioxidant power': the FRAP assay. Anal. Biochem. 1996, 239:70-76.
2. Benzie I.F.F., Szeto Y.T. Total antioxidant capacity of teas by the ferric reducing antioxidant power assay. J. Agric. Food Chem. 1999, 47:633-636.
3. de Mejia E.G., Ramirez-Mares M.V., Puangpraphant S. Bioactive components of tea: Cancer, inflammation and behavior. Brain Behav. Immun. 2009, 23:721-731.
4. Del Rio D., Stewart A.J., Mullen W., et al. HPLC-MS analysis of phenolic compounds and purine alkaloids in green and black tea. J. Agric. Food Chem. 2004, 52:2807-2815.
5. Imai K., Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver disease. Br. Med. J. 1995, 310:693-696.
6. Kono S., Shinchi K., Ikeda N., et al. Green tea consumption and serum lipid profiles: a cross-sectional study in Northern Kysushi, Japan. Prev. Med. 1992, 21:526-531.
7. Lamaison J.L.C., Carnet A. Teneurs en principaux flavonoïdes des fleurs de Crataegus monogyna Jacq et de Crataegus alevigata (Poiret DC) en fonction de la vegetation. Planta Med. Phytother. 1990, XXV:12-16.
8. Langley-Evans S.C. Consumption of black tea elicits an increase in plasma antioxidant potential in humans. Int. J. Food Sci. Nutr. 2000, 51:309-315.
9. Luximon-Ramma A., Bahorun T., Crozier A., et al. Characterization of the antioxidant functions of flavonoids and proanthocyanidins in Mauritian black teas. Food Res. Int. 2005, 38:357-367.
10. Luximon-Ramma A., Neergheen V., Bahorun T., et al. Assessment of the polyphenolic composition of the organic extracts of Mauritian black teas: a potential contributor to their antioxidant function. Biofactors 2006, 27:79-91.
11. Ministry of Health and Quality of Life (Mauritius) The trends in diabetes and cardiovascular disease risk in Mauritius: The Mauritius non communicable diseases survey 2009 2009.
12. Pietta P.G., Simonetti P., Gardana C., et al. Catechin metabolites after intake of green tea infusions. Biofactors 1998, 8:111-118.
13. Porter L.J., Hrstich L.N., Chan B.C. The conversion of procyanidins and prodelphinidins to cyanidins and delphinidins. Phytochemistry 1986, 25:225-230.
14. Rouanet J.M., Décordé K., Del Rio D., et al. Berry juices, teas, antioxidants and the prevention of atherosclerosis in hamsters. Food Chem. 2010, 118:266-271.
15. Serafini M., Ghiselli A., Ferro-Luzzi A. In vivo antioxidant effect of green tea and black tea in man. European J. Clin. Nutr. 1996, 50:28-32.
16. Shao W., Powell C., Cifford M.N., et al. The analysis by HPLC of green, black and Pu'er teas produced in Yunnan. J. Sci. Food Agric. 1995, 69:535-540.
17. Sharangi A.B. Medicinal and therapeutic potentialities of tea (Camellia sinensis L.)-A review. Food Res. Int. 2009, 42:529-535.
18. Shimada K., Kawarabayashi T., Tanaka A., et al. Oolong tea increases plasma adiponectin levels and low-density lipoprotein particle size in patients with coronary artery disease. Diabetes Res. Clin. Pract. 2004, 65:227-234.
19. Singleton V.L., Rossi J.A. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am. J. Enol. Viticult. 1965, 16:144-153.
20. Stangl V., Lorenz M., Stangl K. The role of tea and tea flavonoids in cardiovascular health. Mol. Nutr. Food Res. 2006, 50:218-228.
21. USDA Food Composition database http://www.nal.usda.gov/fnic/foodcomp.
22. van het Hof K.H., de Boer H.S., Wiseman S.A., et al. Consumption of green and black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am. J. Clin. Nutr. 1997, 66:1125-1132.